M. Davies

Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double‐Blind, Placebo‐Controlled 3‐Year Study

J. Kanis, R. Francis, E. McCloskey, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical risk factors alone are insufficient in decision making

M. Davies, P. Selby, 1996, BMJ.

Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysis.

J A Kanis, J. Kanis, R. Francis, 2001, Bone.